文献速递自身免疫性与大疱性皮肤病

寻常型天疱疮棘层松解中ADAM10的作用取决于患者自身抗体谱

The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
PubMed 文献 · Br J Dermatol · 2019-10-15

该研究利用被动转移小鼠模型,采用来自不同患者的三种PV-IgG组分(含高或低水平抗Dsg1/3抗体,伴或不伴抗Dsc抗体),探究ADAM10在棘层松解中的作用。结果显示,仅含抗Dsg1/3而无抗Dsc2/3的IgG组分以Src依赖方式激活ADAM10并增加EGF和BTC;而含抗Dsc2/3者则引发更早、不依赖ADAM10的棘层松解,且无EGF/BTC升高,提示不同自身抗体谱通过不同机制导致棘层松解。

要点

  • 抗Dsg1/3抗体通过Src依赖途径激活ADAM10并上调EGF/BTC。
  • 抗Dsc2/3抗体存在时棘层松解更早且不依赖ADAM10,无EGF/BTC升高。
  • PV患者棘层松解机制因自身抗体谱而异,提示需个体化治疗。

核心结论

  • 所有PV-IgG组分均引起基底层上棘层松解,但机制因抗体谱不同而异。
  • 抗Dsg1/3抗体介导的棘层松解依赖ADAM10激活,而抗Dsc2/3抗体介导者不依赖ADAM10且发生更早。

研究设计与样本

  • 采用被动转移小鼠模型,使用三种来自不同PV患者的PV-IgG组分,分别含高或低水平抗Dsg1/3抗体,伴或不伴抗Dsc抗体。

主要发现

  • 仅含抗Dsg1/3而无抗Dsc2/3的PV-IgG组分以Src依赖方式诱导ADAM10激活,并增加EGFR配体EGF和BTC。
  • 含抗Dsc2/3抗体的PV-IgG组分引发更早且不依赖ADAM10的表皮松解,无EGF和BTC升高,棘层松解更严重。
  • 较低水平的抗Dsc3抗体与较轻的棘层松解相关。

临床怎么用

  • 对以抗Dsg1/3抗体为主的患者,Src、ADAM10、EGF或EGFR抑制剂可能抑制棘层松解。
  • 对存在抗Dsc2/3抗体的患者,棘层松解更早更重且不依赖ADAM10,需考虑更早干预或不同靶点。

局限性

  • 研究基于小鼠被动转移模型,结果外推至人类PV需谨慎验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acantholysis in pemphigus vulgaris (PV) may be triggered by desmoglein (Dsg) and non-Dsg autoantibodies. The autoantibody profile of each patient results in distinct intracellular signalling patterns. OBJECTIVES: Based on our previous findings, we aimed to elucidate whether PV acantholysis in a mouse model may be mediated by activation of a disintegrin and metalloproteinase 10 (ADAM10). METHODS: We used three PV-IgG fractions from different patients containing high or low levels of anti-Dsg1 and anti-Dsg3 antibodies, and the presence or not of anti-desmocollin (Dsc) antibodies, using a passive transfer mouse model of PV. RESULTS: Although all of the PV-IgG fractions produced suprabasal acantholysis, only those containing anti-Dsg1/3, but not anti-Dsc2/3 antibodies, induced ADAM10 activation in a Src-dependent way, and an increase in the epidermal growth factor (EGF) receptor ligands EGF and betacellulin (BTC). In contrast, the presence of anti-Dsc2/3 antibodies, in addition to anti-Dsg1/3, triggered earlier and ADAM10-independent epidermal detachment, with no increase in EGF and BTC, which was associated with an earlier and more intense acantholysis. CONCLUSIONS: All PV-IgG fractions produced suprabasal acantholysis, but our results reveal that depending on the levels of anti-Dsg antibodies or the presence of non-Dsg antibodies, such as anti-Dsc, more severe cell-cell epidermal detachment will occur at different times, and in an ADAM10-dependent manner or not. Acantholysis in these different groups of patients with PV may be a consequence of the activation of specific intracellular mechanisms downstream of Autoantibodies binding to Dsg or non-Dsg proteins, and therefore more specific therapeutic approaches in PV should be used. What's already known about this topic? Suprabasal acantholysis in pemphigus vulgaris (PV) may be triggered by both desmoglein (Dsg) and non-Dsg autoantibodies. The autoantibody profile of each patient is associated with a distinct intracellular signalling pattern. What does this study add? In patients with PV with anti-Dsg3 and anti-Dsg1, but not anti-desmocollin (Dsc)3 antibodies, ADAM10 activation is induced in an Src-dependent way, together with an increase in the epidermal growth factor receptor (EGFR) ligands EGF and betacellulin. The presence of anti-Dsc3 antibodies triggers an earlier and ADAM10-independent acantholysis, without increasing EGFR ligands, and is associated with more severe epidermal detachment. Lower levels of anti-Dsc3 antibodies are associated with less severe acantholysis. What is the translational message? In some patients with PV, the severity and the timing for cell-cell detachment seem to depend on the level of anti-Dsg1/3 antibodies, although other as yet uncharacterized antibodies may also participate. These patients with PV would exhibit inhibition of acantholysis by Src, ADAM10, EGF and EGFR inhibitors. In other patients, the presence of non-Dsg antibodies, such as anti-Dsc2/3, would produce an earlier and more severe ADAM10-independent suprabasal acantholysis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Ivars M, España A, Alzuguren P, et al. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient. Br J Dermatol. 2019. PMID: 31370093. doi:10.1111/bjd.18382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。